All effects fixed [Two-Stage / GS Designs]

posted by kumarnaidu – Mumbai, India, 2013-12-09 08:33 (4573 d 03:28 ago) – Posting: # 12024
Views: 28,817

Thanks Helmut. I think like new FDA draft guidance EMA should also include the provision of submitting complete protocol for review and comment before study initiation in sequential design to avoid such situations.:-D

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
157 visitors (0 registered, 157 guests [including 23 identified bots]).
Forum time: 13:01 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5